Amylyx Pharmaceuticals Inc (AMLX)
1.93
+0.12
(+6.63%)
USD |
NASDAQ |
May 01, 16:00
1.93
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Gross Profit Margin (Quarterly): 91.37% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 91.37% |
September 30, 2023 | 94.92% |
June 30, 2023 | 94.32% |
Date | Value |
---|---|
March 31, 2023 | 92.60% |
December 31, 2022 | 87.11% |
September 30, 2022 | 50.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
50.14%
Minimum
Sep 2022
94.92%
Maximum
Sep 2023
85.08%
Average
91.99%
Median
Gross Profit Margin (Quarterly) Benchmarks
Cassava Sciences Inc | -- |
iRhythm Technologies Inc | 65.98% |
Bristol-Myers Squibb Co | 75.29% |
Moderna Inc | 66.97% |
ACADIA Pharmaceuticals Inc | 92.26% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 12.75% |
Return on Assets | 11.01% |
Return on Invested Capital | 12.75% |
Profit Margin (Quarterly) | 4.36% |
Operating Margin (Quarterly) | 1.78% |
Return on Net Operating Assets | 84.79% |